CLINICAL_TRIALS
withdrawal
· 2016-08-11
Clinical Trial Update: Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function [Phase 2]
Summary
A Phase 2 clinical trial evaluating isosorbide mononitrate for hypertension to improve left ventricular hypertrophy, fibrosis, and myocardial function has been …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Corporal Michael J. Crescenz VA Medical Center | Conditions: Hypertension | Phase 2 | Status: WITHDRAWN